BERLIN (Reuters) - There is no reason to stockpile the generic steroid drug dexamethasone, a German health ministry spokesman said on Wednesday, after British trial data showed it reduced death rates among patients with the most severe COVID-19 infections.
Reporting by Thomas Seythal; Editing by Alex Richardson
Our Standards: The Thomson Reuters Trust Principles.